← Back to Find a Trial

Recruiting

Transdiagnostic Internet Cognitive-behavior Therapy for Mixed Anxiety and Depressive Symptoms in Postnatal Women

Châteauguay, Quebec (+3 more) · Ages 18+ · Therapy / behavioral · NCT06778096

This research project aims to examine the acceptability and efficacy of a French-Canadian adaptation of a postnatal anxiety and depression program. The main question it aims to answer is:

\[1\] When the adapted postnatal Internet-delivered cognitive behavioral therapy (iCBT) is added to treatment as usual (TAU) in community-based care for women with anxiety and depressive symptoms, is the iCBT+TAU condition more effective to reduce symptoms than TAU alone?

Participants will

postnatal iCBT group -\> Answer questionnaires before, after (week 6) and 4 weeks after the intervention (week 10); do the 6-week non-guided iCBT program for anxiety and depressive symptoms during the postnatal period.

Waitlist, TAU group -\> Answer questionnaires at enrolment, at week 6 and week 10. Participants will have access to the intervention after they complete their last questionnaires.

Inclusion Criteria

  • 18 years and older
  • Being within 12 months postpartum
  • Fluent in spoken and written French
  • Self-reported clinical score ≥10 for anxiety and/or depressive symptoms based on the Generalised Anxiety Disorder-7 (GAD-7) and the Edinburgh Postnatal Depression Scale 10-item scale (EPDS)
  • Access to a computer/tablet and internet connection
  • Agreement to share primary provider contact information

Exclusion Criteria

  • Self-reported diagnosis of schizophrenia or bipolar disorder
  • Current substance abuse or dependence
  • Current use of benzodiazepines
  • Beginning psychological therapy (\< 4 weeks ago) or medication (\< 8 weeks ago) for depression/anxiety
  • Severe depression (EPDS score ≥ 23) or active suicidal intentions (EPDS question 10 = 3, yes quite often)

View official listing on ClinicalTrials.gov ↗

This page is for general information only and is not a guarantee of eligibility or enrollment. Trial details are subject to change — the study site will confirm final eligibility criteria.